Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
Condition(s):SCLC, Extensive StageLast Updated:February 21, 2021Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):SCLC, Extensive StageLast Updated:February 21, 2021Not yet recruiting
Condition(s):Small Cell Lung CancerLast Updated:September 6, 2019Recruiting
Condition(s):Small Cell Lung CancerLast Updated:February 1, 2018Completed
Condition(s):Small-cell Lung Cancer; Small Cell Lung CarcinomaLast Updated:June 16, 2020Recruiting
Condition(s):Small Cell Lung CarcinomaLast Updated:October 24, 2017Completed
Condition(s):Small-cell Lung CancerLast Updated:June 9, 2020Recruiting
Condition(s):Extensive Stage Small Cell Lung CarcinomaLast Updated:July 23, 2019Completed
Condition(s):Recurrent Small Cell Lung CarcinomaLast Updated:May 16, 2016Terminated
Condition(s):Small-cell Lung Cancer; Small Cell Lung CarcinomaLast Updated:February 11, 2021Recruiting
Condition(s):Small Cell Lung Cancer; Small Cell Lung CarcinomaLast Updated:February 2, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.